Vimarsana
Biggest News Aggregation in the World

Page 2 - Third Harmonic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Third Harmonic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Third Harmonic Today - Breaking & Trending Today

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results - Vimarsana News

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

Published: March 29, 2023

Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory DiseasesSAN FRANCISCO, March 29, 2023 -- Third Harmonic Bio, Inc. , a biopharmaceutical company... | March 29, 2023

Source: marketscreener.com
Related Topics:
Lori MurrayNatalie HollesExchange CommissionThird Harmonic Bio IncCompany Progresses PreclinicalCompany Progresses Preclinical Next GenerationMast Cell Mediated InflammatoryHarmonic BioChief Executive OfficerThird HarmonicBusiness HighlightsThird Harmonic BioSecurities Litigation Reform ActAnnual ReportEnded DecemberNc Stock ExchangePress ReleaseIopharmaceutical Thrd Us88427a1079
Third Harmonic halts study of lead drug over safety risk - Vimarsana News

Third Harmonic halts study of lead drug over safety risk

Published: December 15, 2022

BioPharma

Source: biopharmadive.com
Related Topics:
Dive BriefHarmonic BioThird HarmonicAtlas Venture BackedClinical Trials
Acelyrin Raises $300M to Further Growth - San Fernando Valley Business Journal - Vimarsana News

Acelyrin Raises $300M to Further Growth - San Fernando Valley Business Journal

Published: September 26, 2022

Acelyrin Inc. has raised $300 million in a Series C round to accelerate its treatments for inflammatory diseases.

Source: sfvbj.com
Related Topics:
Woodland HillsUnited StatesMenlo ParkPalo AltoSan FranciscoWestlake VillageMarshall WaceLos AngelesSean HarperEli LillyShao Lee LinDan BeckerEuropean UnionDrug AdministrationAcelyrin IncLee LinBusiness JournalAccess BiotechnologyWestlake Village BiopartnersMatrix Capital ManagementCowen Healthcare InvestmentsDecheng CapitalSamsara BiocapitalSurveyor CapitalTybourne Capital Management
Prime Medicine becomes the next high-profile biotech to test the IPO waters - Vimarsana News

Prime Medicine becomes the next high-profile biotech to test the IPO waters

Published: September 26, 2022

BioPharma

Source: biopharmadive.com
Related Topics:
David LiuKeith GottesdienerLyell ImmunopharmaBausch LombExchange CommissionBausch HealthDive BriefPrime MedicineBeam TherapeuticsEditas MedicineRenaissance CapitalBiopharma DiveThird Harmonic BioThird HarmonicSana BiotechnologyCaribou BiosciencesVenture PartnersF Prime Capital PartnersNewpath Partners
Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Portfolio Company Update: Third Harmonic Bio IPO - Vimarsana News

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Portfolio Company Update: Third Harmonic Bio IPO

Published: September 16, 2022

Investegate announcements from RTW Venture Fund Ltd, Portfolio Company Update: Third Harmonic Bio IPO

Source: investegate.co.uk
Related Topics:
New YorkUnited StatesUnited KingdomCity OfStephanie SirotaLori MurrayAlexandra TaracanovaGeorge BealeBroderick WongCharles RylandHenry WilsonVenture Fund Limited The CompanyMorgan StanleyVenture FundBroadridge Financial SolutionsThird Harmonic Bio IncExchange CommissionProspectus DepartmentEquity Syndicate Prospectus DepartmentPortfolio CompanyMorgan Stanley CoVenture Fund LimitedCompany UpdateThird Harmonic BioHarmonic Bio Prices Upsized